연구성과로 돌아가기

2024 연구성과별 연구자 정보 (263 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis Kim, In-Ho Kim, IH 5 Catholic Univ Korea, Seoul St Marys Hosp, Dept Oncol, Seoul, South Korea JXL-8219-2024 Kim, Sung-Bae ykkang@amc.seoul.kr;
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis Kim, Jong Gwang Kim, JG 6 Kyungpook Natl Univ, Chilgok Hosp, Daegu, South Korea ykkang@amc.seoul.kr;
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis Li, Yong Li, Y 7 Hebei Med Univ, Dept Orthoped, Hosp 4, Shijiazhuang, Hebei, Peoples R China ykkang@amc.seoul.kr;
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis Yan, Zhuchen Yan, ZC 8 Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China ykkang@amc.seoul.kr;
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis Li, Jin Li, J 9 Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China ykkang@amc.seoul.kr;
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis Bai, Li-Yuan Bai, LY 10 China Med Univ Hosp, Div Hematol & Oncol, Taichung, Taiwan ykkang@amc.seoul.kr;
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis Chan, Catherine Chan, CTRE 11 Amgen Inc, Thousand Oaks, CA USA ykkang@amc.seoul.kr;
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis Yusuf, Akeem Yusuf, A 12 Amgen Inc, Thousand Oaks, CA USA ykkang@amc.seoul.kr;
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis Zahlten-Kuemeli, Anita Zahlten-Kuemeli, A 13 Amgen Inc, Thousand Oaks, CA USA ykkang@amc.seoul.kr;
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis Taylor, Kate Taylor, K 14 Amgen Ltd, Uxbridge, England ykkang@amc.seoul.kr;
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis Yamaguchi, Kensei Yamaguchi, K 15 JFCR, Gastroenterol Chemotherapy Dept, Canc Inst Hosp, Koto Ku, Tokyo, Japan ykkang@amc.seoul.kr;
Benchmarking Real-World Many-Objective Problems: A Problem Suite With Baseline Results Palakonda, Vikas Palakonda, V 1 Kyungpook Natl Univ, Dept Artificial Intelligence, Daegu 41566, South Korea jmkang@knu.ac.kr;heechul@knu.ac.kr;
Benchmarking Real-World Many-Objective Problems: A Problem Suite With Baseline Results Kang, Jae-Mo Kang, JM 2 교신저자 Kyungpook Natl Univ, Dept Artificial Intelligence, Daegu 41566, South Korea 0000-0002-8181-5994 Kang, Jae-Mo jmkang@knu.ac.kr;heechul@knu.ac.kr;
Benchmarking Real-World Many-Objective Problems: A Problem Suite With Baseline Results Jung, Heechul Jung, HC 3 교신저자 Kyungpook Natl Univ, Dept Artificial Intelligence, Daegu 41566, South Korea jmkang@knu.ac.kr;heechul@knu.ac.kr;
Benchmarking the performance and uncertainty of machine learning models in estimating scour depth at sluice outlets Le, Xuan-Hien Le, XH 1 교신저자 Kyungpook Natl Univ, Dept Adv Sci & Technol Convergence, 2559 Gyeongsang Daero, Sangju 37224, South Korea AAZ-9166-2021 Le, Xuan-Hien 0000-0002-0947-0805 Le, Xuan-Hien hienlx@knu.ac.kr;
페이지 이동: